Steroid-sensitive nephrotic syndrome: Do children with early onset of <4 years of age, really need standard therapy?

Background: There are no separate guidelines available for the management of pediatric population with early onset nephrotic syndrome, even if they have difficult disease course. So we conducted this study to analyze the response of the standard steroid regime in these children with early onset (<...

Full description

Saved in:
Bibliographic Details
Main Authors: Kriti Mohan, Mahima Mittal, Manish Kumar, Anchala Bhardwaj
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-06-01
Series:Journal of Family Medicine and Primary Care
Subjects:
Online Access:https://journals.lww.com/10.4103/jfmpc.jfmpc_1378_24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849420938665263104
author Kriti Mohan
Mahima Mittal
Manish Kumar
Anchala Bhardwaj
author_facet Kriti Mohan
Mahima Mittal
Manish Kumar
Anchala Bhardwaj
author_sort Kriti Mohan
collection DOAJ
description Background: There are no separate guidelines available for the management of pediatric population with early onset nephrotic syndrome, even if they have difficult disease course. So we conducted this study to analyze the response of the standard steroid regime in these children with early onset (<4 years) steroid-sensitive nephrotic syndrome. Methods: This was a retrospective comparative study with follow-up. Data from children having steroid-sensitive nephrotic syndrome were recorded and divided into two groups: disease onset >1 to ≤4 years of age and disease onset >4 to 10 years of age, and the outcome in these children, treated with standard steroid regimen, was compared. Results: This study included a total of 41 children. Fewer days taken to remission in the first episode, more number of relapses within 6 months of treated first episode, and more number of infection-triggered relapses were significantly associated with the early onset group, while significantly more days were taken to remission in group 2. There was no difference statistically in both cohorts in terms of disease limitation to first episode, no. of mean relapses, cumulative steroid doses, and the need for steroid-sparing agents. Conclusion: More days taken to remission in relapses and more no. of relapses within 6 months of treatment, still no need for increased steroid cumulative doses and steroid-sparing drugs in early onset nephrotic syndrome, defy the need for different therapies or regimes, but in view of significant infection-triggered relapses, role of general hygienic measures, nutrition, and vaccination must be emphasized in these children.
format Article
id doaj-art-3d2a1adec68344d2bd3861c19f534f09
institution Kabale University
issn 2249-4863
2278-7135
language English
publishDate 2025-06-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Family Medicine and Primary Care
spelling doaj-art-3d2a1adec68344d2bd3861c19f534f092025-08-20T03:31:35ZengWolters Kluwer Medknow PublicationsJournal of Family Medicine and Primary Care2249-48632278-71352025-06-011462143214710.4103/jfmpc.jfmpc_1378_24Steroid-sensitive nephrotic syndrome: Do children with early onset of <4 years of age, really need standard therapy?Kriti MohanMahima MittalManish KumarAnchala BhardwajBackground: There are no separate guidelines available for the management of pediatric population with early onset nephrotic syndrome, even if they have difficult disease course. So we conducted this study to analyze the response of the standard steroid regime in these children with early onset (<4 years) steroid-sensitive nephrotic syndrome. Methods: This was a retrospective comparative study with follow-up. Data from children having steroid-sensitive nephrotic syndrome were recorded and divided into two groups: disease onset >1 to ≤4 years of age and disease onset >4 to 10 years of age, and the outcome in these children, treated with standard steroid regimen, was compared. Results: This study included a total of 41 children. Fewer days taken to remission in the first episode, more number of relapses within 6 months of treated first episode, and more number of infection-triggered relapses were significantly associated with the early onset group, while significantly more days were taken to remission in group 2. There was no difference statistically in both cohorts in terms of disease limitation to first episode, no. of mean relapses, cumulative steroid doses, and the need for steroid-sparing agents. Conclusion: More days taken to remission in relapses and more no. of relapses within 6 months of treatment, still no need for increased steroid cumulative doses and steroid-sparing drugs in early onset nephrotic syndrome, defy the need for different therapies or regimes, but in view of significant infection-triggered relapses, role of general hygienic measures, nutrition, and vaccination must be emphasized in these children.https://journals.lww.com/10.4103/jfmpc.jfmpc_1378_24childhood nephrotic syndromepediatrictherapysteroid therapy
spellingShingle Kriti Mohan
Mahima Mittal
Manish Kumar
Anchala Bhardwaj
Steroid-sensitive nephrotic syndrome: Do children with early onset of <4 years of age, really need standard therapy?
Journal of Family Medicine and Primary Care
childhood nephrotic syndrome
pediatric
therapy
steroid therapy
title Steroid-sensitive nephrotic syndrome: Do children with early onset of <4 years of age, really need standard therapy?
title_full Steroid-sensitive nephrotic syndrome: Do children with early onset of <4 years of age, really need standard therapy?
title_fullStr Steroid-sensitive nephrotic syndrome: Do children with early onset of <4 years of age, really need standard therapy?
title_full_unstemmed Steroid-sensitive nephrotic syndrome: Do children with early onset of <4 years of age, really need standard therapy?
title_short Steroid-sensitive nephrotic syndrome: Do children with early onset of <4 years of age, really need standard therapy?
title_sort steroid sensitive nephrotic syndrome do children with early onset of 4 years of age really need standard therapy
topic childhood nephrotic syndrome
pediatric
therapy
steroid therapy
url https://journals.lww.com/10.4103/jfmpc.jfmpc_1378_24
work_keys_str_mv AT kritimohan steroidsensitivenephroticsyndromedochildrenwithearlyonsetof4yearsofagereallyneedstandardtherapy
AT mahimamittal steroidsensitivenephroticsyndromedochildrenwithearlyonsetof4yearsofagereallyneedstandardtherapy
AT manishkumar steroidsensitivenephroticsyndromedochildrenwithearlyonsetof4yearsofagereallyneedstandardtherapy
AT anchalabhardwaj steroidsensitivenephroticsyndromedochildrenwithearlyonsetof4yearsofagereallyneedstandardtherapy